APA

Agache I., Rocha C., Beltran J., Song Y., Posso M., Solà I., Alonso-Coello P., Akdis C., Akdis M., Canonica G. W., Casale T., Chivato T., Corren J., Del Giacco S., Eiwegger T., Firinu D., Gern J. E., Hamelmann E., Hanania N., Mäkelä M., Martín I. H., Nair P., O'Mahony L., Papadopoulos N. G., Papi A., Park H., Pérez de Llano L., Quirce S., Sastre J., Shamji M., Schwarze J., Canelo-Aybar C., Palomares O. & Jutel M. (20210514). Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. : Allergy.

Chicago

Agache Ioana, Rocha Claudio, Beltran Jessica, Song Yang, Posso Margarita, Solà Ivan, Alonso-Coello Pablo, Akdis Cezmi, Akdis Mubeccel, Canonica Giorgio W, Casale Thomas, Chivato Tomas, Corren Jonathan, Del Giacco Stefano, Eiwegger Thomas, Firinu Davide, Gern James E, Hamelmann Eckard, Hanania Nicola, Mäkelä Mika, Martín Irene Hernández, Nair Parameswaran, O'Mahony Liam, Papadopoulos Nikolaos G, Papi Alberto, Park Hae-Sim, Pérez de Llano Luis, Quirce Santiago, Sastre Joaquin, Shamji Mohamed, Schwarze Jurgen, Canelo-Aybar Carlos, Palomares Oscar and Jutel Marek. 20210514. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. : Allergy.

Harvard

Agache I., Rocha C., Beltran J., Song Y., Posso M., Solà I., Alonso-Coello P., Akdis C., Akdis M., Canonica G. W., Casale T., Chivato T., Corren J., Del Giacco S., Eiwegger T., Firinu D., Gern J. E., Hamelmann E., Hanania N., Mäkelä M., Martín I. H., Nair P., O'Mahony L., Papadopoulos N. G., Papi A., Park H., Pérez de Llano L., Quirce S., Sastre J., Shamji M., Schwarze J., Canelo-Aybar C., Palomares O. and Jutel M. (20210514). Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. : Allergy.

MLA

Agache Ioana, Rocha Claudio, Beltran Jessica, Song Yang, Posso Margarita, Solà Ivan, Alonso-Coello Pablo, Akdis Cezmi, Akdis Mubeccel, Canonica Giorgio W, Casale Thomas, Chivato Tomas, Corren Jonathan, Del Giacco Stefano, Eiwegger Thomas, Firinu Davide, Gern James E, Hamelmann Eckard, Hanania Nicola, Mäkelä Mika, Martín Irene Hernández, Nair Parameswaran, O'Mahony Liam, Papadopoulos Nikolaos G, Papi Alberto, Park Hae-Sim, Pérez de Llano Luis, Quirce Santiago, Sastre Joaquin, Shamji Mohamed, Schwarze Jurgen, Canelo-Aybar Carlos, Palomares Oscar and Jutel Marek. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. : Allergy. 20210514.